1-2 of 2
for the Group for Research on Adult Acute Lymphoblastic Leukemia
Close
Sort by
Journal Articles

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study

Clinical Trials & Observations
Raouf Ben Abdelali, Vahid Asnafi, Thibaut Leguay, Nicolas Boissel, Agnès Buzyn, Patrice Chevallier, Xavier Thomas, Stephane Lepretre, Françoise Huguet, Norbert Vey, Martine Escoffre-Barbe, Emmanuelle Tavernier, Oumedaly Reman, Nathalie Fegueux, Pascal Turlure, Philippe Rousselot, Jean-Yves Cahn, Veronique Lheritier, Yves Chalandon, Marie-Christine Béné, Elizabeth Macintyre, Hervé Dombret, Norbert Ifrah, for the Group for Research on Adult Acute Lymphoblastic Leukemia
Journal: Blood
Blood (2011) 118 (19): 5099–5107.
https://doi.org/10.1182/blood-2011-02-334219
Published: 2011
Includes: Supplemental data
Journal Articles

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study

Clinical Trials & Observations
Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet-Rigal, Eric Delabesse, Francis Witz, Sébastien Maury, Delphine Réa, Jean-Michel Cayuela, Marie-Christine Vekemans, Oumedaly Reman, Agnès Buzyn, Arnaud Pigneux, Martine Escoffre, Yves Chalandon, Elizabeth MacIntyre, Véronique Lhéritier, Jean-Paul Vernant, Xavier Thomas, Norbert Ifrah, Hervé Dombret, for the Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
Journal: Blood
Blood (2006) 109 (4): 1408–1413.
https://doi.org/10.1182/blood-2006-03-011908
Published: 2006
Includes: Supplemental data